- Posted:
Pregabalin: what the patent litigation means for doctors and drug companies
Explaining the arguments over the Pregabalin patent case and explore the wider implications for the NHS and drug development
Darren Smyth, Richard Croker, and Ben Goldacre explain the arguments over the patent case and explore the wider implications for the NHS and drug development
- Ben Goldacre,
- Darren Smyth,
- Richard Croker